Gallbladder cancer future or investigational therapies: Difference between revisions
Varun Kumar (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Gallbladder cancer}} | {{Gallbladder cancer}} | ||
{{CMG}} | {{CMG}} | ||
| Line 4: | Line 5: | ||
==Overview== | ==Overview== | ||
== | ==Future or Investigational Therapies== | ||
Clinical trials are exploring ways of improving local control with radiation therapy combined with radiosensitizer drugs. When possible, such patients are appropriately considered candidates for these studies. | Clinical trials are exploring ways of improving local control with radiation therapy combined with radiosensitizer drugs. When possible, such patients are appropriately considered candidates for these studies. | ||
| Line 13: | Line 14: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 20:25, 11 September 2012
|
Gallbladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gallbladder cancer future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Gallbladder cancer future or investigational therapies |
|
FDA on Gallbladder cancer future or investigational therapies |
|
CDC on Gallbladder cancer future or investigational therapies |
|
Gallbladder cancer future or investigational therapies in the news |
|
Blogs on Gallbladder cancer future or investigational therapies |
|
Risk calculators and risk factors for Gallbladder cancer future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Future or Investigational Therapies
Clinical trials are exploring ways of improving local control with radiation therapy combined with radiosensitizer drugs. When possible, such patients are appropriately considered candidates for these studies.